What is Malaria Consortium's mission?
Malaria Consortium's mission is "to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health."
What does Malaria Consortium do?
- Malaria Consortium works on a variety of measures to prevent the spread of communicable diseases.
- Through its seasonal malaria chemoprevention program, Malaria Consortium provides antimalarial medicine to children in at-risk areas during seasons of, particularly high transmission rates.
- Malaria Consortium aims to provide four months of treatment for each individual. Up to four treatment courses are given over those four months, providing protection up to one month after the end of the final course.
- Malaria Consortium supports community health workers in delivering treatments by going door-to-door or by treating people in a community centre.
- In 2021, they aim to reach 16 million children in Burkina Faso, Chad, Nigeria, Togo, and Uganda.
Why do we recommend Malaria Consortium?
- Malaria Consortium has a successful track record of running its SMC program in Burkina Faso, Chad, and Nigeria. In 2020, they expanded their SMC work to Togo. They are currently looking into expansion to Mozambique and Uganda.
- There is good evidence that SMC programs are a cost-effective way to prevent malaria. GiveWell tentatively estimates that the cost for a four-month Malaria Consortium SMC treatment is about $6.59 per child.
- Malaria Consortium has conducted studies in most of the countries where it has worked to determine how successfully it has reached the targeted population. These studies have found high rates of reach.
- Seasonal malaria chemoprevention is expected to have a large need for more funding worldwide. GiveWell expects that Malaria Consortium is especially well-placed to effectively use more funds.
To learn more about Malaria Consortium, we recommend reading GiveWell's detailed review.